Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-25-013986
Filing Date
2025-03-20
Accepted
2025-03-20 07:06:14
Documents
94
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avtx-20241231.htm   iXBRL 10-K 2201840
2 EX-4.5 ex-452024descriptionofregi.htm EX-4.5 48707
3 EX-10.14 ex-1014avaloformofindemnif.htm EX-10.14 66982
4 EX-19.1 ex-191insidertradingpolicy.htm EX-19.1 45187
5 EX-21.1 ex-2112024listofsubsidiari.htm EX-21.1 3685
6 EX-23.1 ex-2312024.htm EX-23.1 17637
7 EX-31.1 ex-3112024.htm EX-31.1 10532
8 EX-31.2 ex-3122024.htm EX-31.2 10318
9 EX-32.1 ex-3212024.htm EX-32.1 11095
10 EX-97.1 ex-971incentivecompensatio.htm EX-97.1 28916
16 GRAPHIC avtx-20241231_g1.jpg GRAPHIC 215961
  Complete submission text file 0001628280-25-013986.txt   11085768

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20241231.xsd EX-101.SCH 76081
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avtx-20241231_cal.xml EX-101.CAL 96213
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avtx-20241231_def.xml EX-101.DEF 440720
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20241231_lab.xml EX-101.LAB 900972
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20241231_pre.xml EX-101.PRE 670734
97 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20241231_htm.xml XML 1131567
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37590 | Film No.: 25754471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)